Statistically significant means there is a very high likelihood the drug impacted its target. But if data are not clinically ...

The energy component—and cost—associated with artificial intelligence should not be overlooked in all the excitement.

The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.

Approval makes Gomekli the first treatment to be approved for both adults and pediatric patients for neurofibromatosis type 1 ...

Monica Martin de Bustamante, senior partner and head of advisory at Trinity Life Sciences, spoke with Pharmaceutical ...

While the pandemic may feel like something that’s passed by, COVID-19 still has a significant impact on the general ...

Funding was led by New Enterprise Associates, with participation from Foresite Capital and multiple other investors.

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI compares ...

Each year, Phesi releases an analysis of the world’s most studied diseases. The survey includes data from the 67,569 ...

Biljana Naumovic discusses how a new study attempted to bring in patients from underserved communities.